RecallRadar

FDA Drug recall D-0010-2016

Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg Inhalation Solution, packaged in 30x3 mL Sterile Unit-Dose Vials, a) 30 count (NDC 04…

On 2015-10-21 the FDA classified a Class II recall of Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg Inhalation Solution, packaged in 30x3 mL Sterile Unit-Dose Vials, a) 30 count (NDC 04… by Nephron Pharmaceuticals, citing lack of Assurance of Sterility; potential exposure to non-sterile lubricant during the filling process.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0010-2016
ClassificationClass II
Statusterminated
Initiated2015-08-21
Published2015-10-21
Last updated2026-09-13 11:51 UTC
CompanyNephron Pharmaceuticals
DistributionUS

Product

Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg Inhalation Solution, packaged in 30x3 mL Sterile Unit-Dose Vials, a) 30 count (NDC 0487-0201-03) and b) 60 count (NDC 0487-0201-60) vials per carton, Rx only, Nephron Pharmaceutical Corporation, Orlando, FL

Reason

Lack of Assurance of Sterility; potential exposure to non-sterile lubricant during the filling process

Identifiers

ndc0487-0201-01
ndc0487-0201-02
ndc0487-0201-03
ndc0487-0201-60
code_infoa) Lot D4E20A, exp 3/2016 and b) Lot D4C21A, exp 3/2016

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0010-2016%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.